Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders - PubMed (original) (raw)

Review

Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders

Yu-Long Lan et al. Ther Adv Endocrinol Metab. 2019.

Abstract

Hormone-sensitive lipase (HSL) is one of the three lipases in adipose tissue present during periods of energy demand. HSL is tightly controlled by insulin regulation via the central and peripheral systems. The suppressive effects of insulin on HSL are also associated with complex crosstalk with other pathways in the metabolic network. Because impaired insulin action is the driving force behind the pathogenesis of diabetes and other metabolic complications, elucidation of the intricate relationships between HSL and insulin may provide an in-depth understanding of these pandemic diseases and potentially identify strategies to inhibit disease development. Insulin not only differentially regulates HSL isoform transcription but also post-transcriptionally affects HSL phosphorylation by stimulating PKA and endothelin (ET-1), and controls its expression indirectly via regulating the activity of growth hormone (GH). In addition, a rapid elevation of HSL levels was detected after insulin injection in patients, which suggests that the inhibitory effects of insulin on HSL can be overridden by insulin-induced hypoglycemia. Conversely, individuals with hereditary HSL deficiency, and animals with experimental HSL deletion, showed major disruptions in mRNA/protein expression in insulin signaling pathways, ultimately leading to insulin resistance, diabetes, and fatty liver. Notably, HSL inactivation could cause insulin-independent fatty liver, while insulin resistance induced by HSL deficiency may further aggravate disease progression. The common beliefs that HSL is the overall rate-limiting enzyme in lipolysis and that insulin is an inhibitor of HSL have been challenged by recent discoveries; therefore, a renewed examination of their relationships is required. In this review, by analyzing current data related to the role of, and mutual regulation between, HSL and insulin and discussing unanswered questions and disparities in different lines of studies, the authors intend to shed light on our understanding of lipid metabolism and provide a rational basis for future research in drug development.

Keywords: hormone-sensitive lipase; insulin; metabolic disorders; treatment.

© The Author(s), 2019.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Figures

Figure 1.

Figure 1.

Schematic depiction of the synergistic effect of HSL and insulin in regulating various metabolic disorders in the human body, including lipotoxicity, T2DM, IR, inflammation, fatty liver, NAFLD, obesity, etc. HSL, hormone-sensitive lipase; IR, insulin resistance; NAFLD, nonalcoholic fatty liver disease; T2DM, type 2 diabetes mellitus.

References

    1. Lampidonis AD, Rogdakis E, Voutsinas GE, et al. The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis. Gene 2011; 477: 1–11. - PubMed
    1. Kraemer FB, Shen WJ. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 2002; 43: 1585–1594. - PubMed
    1. Jaffer I, Riederer M, Shah P, et al. Expression of fat mobilizing genes in human epicardial adipose tissue. Atherosclerosis 2012; 220: 122–127. - PubMed
    1. Jocken JW, Goossens GH, Boon H, et al. Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance. Diabetologia 2013; 56: 2255–2265. - PMC - PubMed
    1. Holysz M, Trzeciak WH. Hormone-sensitive lipase/cholesteryl esterase from the adrenal cortex-structure, regulation and role in steroid hormone synthesis. Postępy Biochemii 2015; 61: 138–146. - PubMed

Publication types

LinkOut - more resources